Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the history. No substantive content changes are evident from the screenshots.
    Difference
    0.1%
    Check dated 2026-03-12T02:49:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history; older notices (v3.4.1 and a government funding banner) were removed. These updates affect the UI/site banners rather than the clinical trial content.
    Difference
    0.5%
    Check dated 2026-02-11T12:00:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A system-wide funding notice was added to the page and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:20.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The history page UI now includes a glossary toggle, color-coded highlights for additions and deletions, and updated revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T03:53:53.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.3.4; the entry for v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:42.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Administrative updates to the history page include a new Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2, which do not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:52:37.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.